Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Heading back to the trough (levels of biologics in IBD).
Natural selection, protein engineering, and the last riboorganism: rational model building in biochemistry.
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Heading back to the trough (levels of biologics in IBD).
Heading back to the trough (levels of biologics in IBD). Clin Gastroenterol Hepatol. 2015 Mar; 13(3):548-51.
View in:
PubMed
subject areas
Anti-Inflammatory Agents
Biological Products
Drug Therapy, Combination
Humans
Immunologic Factors
Inflammatory Bowel Diseases
Serum
Treatment Outcome
authors with profiles
Stephen B. Hanauer